What does Decision Resources Group do?

Our mission is to advance innovation and accelerate patient-centric outcomes. To do this, we help our clients act quickly and confidently by providing access to connected data and solutions that span the entire healthcare ecosystem.

What is DRG Clarivate?

Learn more. This is a groundbreaking event for Clarivate – and for the life sciences industry. DRG is a premier provider of high-value data, analytics and insights to the world’s leading pharma, biotech and medical technology companies.

What company is DRG?

About Decision Resources Group DRG, a subsidiary of Piramal Enterprises Ltd., is the premier source for global healthcare data and market intelligence. A trusted partner for over 20 years, DRG helps companies competing in the global healthcare industry make informed business decisions.

What companies does Clarivate own?

Cortellis Drug Discovery Intelligence. Cortellis Digital Health Intelligence. MetaCore. Cortellis Generics Intelligence (formerly Newport)

What is HTA market access?

Health Technology Assessment Submissions Health technology assessment (HTA) aims to provide timely patient access to therapeutic interventions that offer clinical and economic value to the healthcare system. This is achieved via a comprehensive evaluation of the evidence base.

What was the intent of diagnosis related groups DRGs?

The purpose of the DRGs is to relate a hospital’s case mix to the resource demands and associated costs experienced by the hospital.

How are DRGs grouped?

DRGs are grouped into Medicare Severity Diagnosis Related Groups and have 25 groups. These include PRE-MDCs, Unrelated Operating Room Procedures, and Invalid and Ungroupable DRGs.

Is Clarivate a SPAC?

Company history In May 2019, Clarivate merged with the Churchill Capital Corp SPAC to obtain a public listing on the New York Stock Exchange (NYSE) It currently trades with symbol NYSE:CLVT.

Where is Clarivate located?

Where is Clarivate headquarters? Clarivate headquarters is located at 70 St Mary Axe, London.

What is HTA in pharma?

Abstract. Increasingly, health technology assessment (HTA) is used to aid decisions on the reimbursement of pharmaceuticals or recommendations for their use. The pharmaceutical industry seeks to work in partnership with HTA agencies; however, this presents a number of challenges.

What is market access pharma?

Market Access is the process to ensure that all appropriate patients who would benefit, get rapid and maintained access to the brand at the right price.

What is the benefit of diagnostic related groupings?

The advantages of the DRG payment system are reflected in the increased efficiency and transparency and reduced average length of stay. The disadvantage of DRG is creating financial incentives toward earlier hospital discharges. Occasionally, such polices are not in full accordance with the clinical benefit priorities.